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Nocturnal blood pressure and 24-hour pulse pressure are po- Mortality among hemodialysis patients remains high
tent indicators of mortality in hemodialysis patients. at 20% per year [1], and cardiovascular (CV) diseases
Background. Cardiovascular (CV) complications are the are the leading cause of mortality in this population,leading cause of mortality in hemodialysis patients. The role
accounting for 44% of overall mortality [2]. The proba-of arterial hypertension on the prognosis of CV in hemodialysis
bility of CV death is 50% after 10 years [3–6]. For hemo-patients is not as clear as in the general population. The purpose
of this study was to investigate the prognostic role of ambula- dialysis patients aged 15 to 30 years, the incidence of
tory blood pressure (BP) on CV mortality in treated hyperten- CV death is 150 times greater than in the general popula-
sive hemodialysis patients. tion [7]. Although hypertension is a major CV risk factorMethods. Fifty-seven treated hypertensive hemodialysis pa-
in end-stage renal disease (ESRD) patients, its influencetients (56.87 6 16.22 years, 30 men) were prospectively studied.
on the CV prognosis remains controversial. WhereasAll patients initially underwent an ambulatory BP monitoring
between two dialysis sessions. The outcome event studied was numerous reports show its deleterious influence on CV
CV death; kidney transplantation and deaths not related to CV prognosis as in the general population, others find no
disease were censored.
relationship between hypertension and survival. ZagerResults. The duration of follow-up was 34.4 6 20.39 months,
et al found a “U”-curve relationship between systolicduring which 10 CV and 8 non-CV fatal events occurred. In
the 10 patients who died from CV complications, age, previous blood pressure (BP) and mortality in dialysis patients
CV events, ambulatory systolic BP, ambulatory pulse pressure [8]. A negative relationship between diastolic BP and
(PP), and life-long smoking level were significantly higher, and CV mortality has been shown by Blacher et al [9]. In a
the office diastolic BP was lower at the time of inclusion than
longitudinal study by Kimura et al, no significant effectin those who did not die from CV complications (N 5 47).
was found between BP and survival in older patients orBased on Cox analysis and after adjustment for age, sex, and
previous CV events, a low office diastolic BP [relative risk in subjects with a previous history of CV complications;
(RR) 0.49, 95% CI, 0.25 to 0.93, P 5 0.03], an elevated 24- on the other hand, in hypercholesterolemic and in pa-
hour PP (RR 1.85, 95% CI, 1.28 to 2.65, P 5 0.009), and an tients who smoked, elevated systolic BP significantlyelevated nocturnal systolic BP (RR 1.41, 95% CI, 1.08 to 1.84,
worsened the survival rate [10].P 5 0.01) were predictors of CV mortality (RR associated with
In essential hypertension, the CV prognosis is morea 10 mm Hg increase in BP and in PP).
Conclusion. This study demonstrates that nocturnal BP and closely associated with ambulatory BP than with clinic
24-hour PP are independent predictors of CV mortality in BP [11]. Moreover, the deleterious influence of an in-
treated hypertensive hemodialysis patients. Randomized trials creased nocturnal BP on target organ damage and CVare needed to investigate whether nocturnal BP and 24-hour
morbidity has been pointed out [11–13]. In ESRD pa-PP are superior to office BP as targets for antihypertensive
therapy in this high-risk group. tients, arterial hypertension is characterized by an al-
tered circadian BP rhythm [14]. This lack of fall in noctur-
nal BP in hemodialysis patients could be related to an
increased sympathetic nervous system activity [15, 16]
caused by afferent renal reflexes. Also, a link between
circadian BP impairment and arterial stiffness has beenKey words: cardiovascular mortality, hemodialysis, hypertension, am-
bulatory blood pressure, pulse pressure. shown in ESRD patients [17]. The purpose of this study
was to investigate the prognostic role of ambulatory BPReceived for publication May 12, 1999
and especially the influence of nighttime ambulatory BPand in revised form December 21, 1999
Accepted for publication January 17, 2000 on CV mortality in treated hypertensive hemodialysis
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METHODS tine. Each time a reading was taken, subjects were in-
structed to remain motionless. The recorder automati-Patients
cally discarded false readings (for example, arm in
Fifty-seven patients on hemodialysis receiving antihy- motion or sound interference during recording). Re-
pertensive therapy for more than six months were cordings were included in the study only if at least 85%
screened between 1993 and 1997. The dry weight was of the maximal number of 79 readings during the 24-
reached in all patients and was determined in a routine hour period assessed the deletion criteria. Our study
fashion on the basis of clinical examination. Patients with population was divided in two subgroups according to
evidence of autonomic dysfunction, particularly ortho- the magnitude of the nocturnal BP fall. Usual classifica-
static hypotension, and patients who were not able to tion of nondipper (for example, a nocturnal BP fall of
support ambulatory BP monitoring were excluded. Pa- less than 10%) does not apply to hemodialysis popula-
tients with significant cardiac valvular disease, congestive tion, and we defined nondippers by a night-day ratio
heart failure with ventricular ejection fraction below of 100% or more for systolic or diastolic BP [14]. The
40%, or malignant disorders were also excluded. Eight remaining subjects were classified as dippers. The 24-
patients were diabetic, and 22 had a past history of CV hour ambulatory pulse pressure (PP; difference between
events. A previous history of CV complications was de- 24-h systolic and diastolic BP) was calculated in all pa-
fined as follows: history of myocardial infarction, coro- tients. The 24-hour ambulatory BP of 125/80 mm Hg
nary bypass surgery or coronary angioplasty, angina pec- (equal or lower) was the cut-off point used to identify
toris, symptoms of peripheral vascular diseases, and patients with adequate ambulatory BP according to 1999
cerebrovascular diseases (history of transient ischemic WHO/ISH guidelines [20].
attacks, stroke). The follow-up ended in January of 1999. Blood chemistry. Blood samples were drawn from the
The duration of dialysis therapy was 6.0 6 5.5 years. dialysis access after a 12-hour fast just before the start
Patients were dialyzed three times per week. The dura- of hemodialysis. Phosphoremia, calcemia, and alkaline
tion of dialysis sessions was a four-hour minimum and phosphatase levels were assayed by autoanalyzer (RA
was individually adjusted to control body fluids and 1000; Technicon, Dumont, France) and serum-intact para-
blood chemistry. The dialysate was delivered by a system thyroid hormone (PTH) by radioimmunoassay (Sorin
comprising bicarbonate delivery and ultrafiltration de- Biomedica, Antony, France).
vices. An arteriovenous shunt was used in all patients.
The quality of hemodialysis therapy was assessed by Analysis
Kt/V index calculation during the month before the am- The outcome event studied was CV mortality. CV
bulatory BP measurement (ABPM). deaths included ischemic heart disease, stroke, aorto-
iliac disease, congestive heart failure, and sudden deaths,
Blood pressure measurements defined as witnessed deaths that occurred within one
Casual blood pressure. Office BP was measured be- hour after the onset of acute symptoms, with no evidence
tween two dialysis sessions with a mercury sphygmoma- that violence or accident played any role in the fatal
nometer with cuffs adapted to arm circumference in a outcome. Causes of deaths were obtained from hospital
sitting position according to the recommendations of the records forms. We censored deaths that were not related
British Hypertension Society [18]. Controlled hyperten- to CV disease as well as kidney transplantation. Statisti-
sion was defined as office BP , 140/90 mm Hg. cal analysis was performed on SAS statistical software
Predialytic BP was measured by a nurse using a semi- (SAS Institute Inc., Cary, NC, USA). A difference was
automatic device, based on an oscillometric method considered significant if the P value was below 0.05. The
(Dinamap/Critikon, Creteil, France) with the patients in groups were compared with the two-sample t-test for
the supine position after resting more than five minutes, continuous data and x2 test or Fisher’s exact test for
before starting the dialysis session. In the absence of a categorical data. We used different Cox proportional
universally accepted criterion, a predialytic BP of 150/90 hazards models to determine the relative risks (RRs)
mm Hg (equal or lower) was the cut-off point used to of CV death. For casual and ambulatory BP, the RRs
identify patients with adequate predialytic BP [19]. associated with a 10 mm Hg increase in BP were calcu-
Ambulatory blood pressure measurements. An ABPM lated. We conducted backward stepwise regressions in
(SPACELABS 90207 monitor, Redmond, WA, USA) order to determine the confounding variables that had
was performed between two dialysis sessions. BP was to be introduced into the multivariate models. Insofar
measured every 15 minutes during the daytime period as the number of CV deaths was very different between
(6 a.m. to 10 p.m.) and every 30 minutes during the men and women in bivariate analysis, the variable “sex”
nocturnal period (10 p.m. to 6 a.m.). The monitor was was forced in each model. Also, the models were system-
placed on the arm opposite the arteriovenous fistula. atically age adjusted. Finally, the stepwise regressions
were conducted to adjust our different models on age,Subjects were allowed to follow their normal daily rou-
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sex, and previous CV events. Survival curves were esti- between survival curves was significant (x2 5 4.81, P 5
0.03). After an adjustment for age, sex, and previous CVmated using the Kaplan–Meier method and were com-
pared with the log-rank test. events (Table 4), office diastolic BP (RR 5 0.49, P 5
0.03), 24-hour ambulatory PP (RR 5 2.05, P 5 0.03),
and ambulatory nighttime systolic BP (RR 5 1.41, P 5
RESULTS
0.01) were significantly associated with CV mortality.
Study population The relative risk associated with a nondipper status was
close to significance (P 5 0.06).The duration of follow-up was 34.4 6 20.39 months,
during which 10 CV and 8 non-CV fatal events occurred.
The eight patients (3 men) who died from non-CV deaths
DISCUSSION
were older (67.87 6 7.25 vs. 55.08 6 16.61 years old, P 5
Cardiovascular complications are the main cause of0.03), had a lower total cholesterol level (4.33 6 0.92 vs.
morbidity and mortality in ESRD patients. In a dialysis5.44 6 1.05 mmol/L, P 5 0.01), and tended to have a
population, the overall risk of cardiac death increaseslower casual and ambulatory diastolic BP (P , 0.1),
by a factor of 5 to 20 [21]. From the U.S. Renal Datawhile nonsignificant differences in sex, office systolic BP,
System [2] for the period from 1993 through 1995, theand ambulatory systolic BP were observed. Among CV
adjusted overall death rate for patients on dialysis wasdeaths, one was attributed to stroke, one to aortic dissec-
243 deaths per 1000 patients years. Arterial hypertensiontion, one to mesenteric infarction, two to sudden death,
represents the main CV risk factor in this population.two following vascular surgery (aortic aneurysm), two
Despite the fact that CV disease is the most commonrelated to congestive heart failure, and one to aorto-
cause of death in hemodialysis patients, BP is poorlyiliac disease. The baseline characteristics of our cohort
controlled in the majority. In a cohort of 649 hemodialy-according to prognosis (CV death or not) are shown in
sis patients, only 28% of subjects had controlled hyper-Table 1. Age, sex, albuminemia, prevalence of previous
tension [22]. Rahman et al, in a study of 489 hemodialysisCV complications, number of antihypertensive drugs,
patients, found that 48% had an inadequate predialysislife-long smoking level, systolic ambulatory BP, and 24-
BP [23]. Using 24-hour ambulatory BP monitoring in 53hour ambulatory PP were significantly different between
hypertensive hemodialysis patients, it has been shownthe two groups. Office and predialytic diastolic BP were
that only 15% were at the goal level [24]. Closely relatedsignificantly lower. Nondipper status tended to be more
to these rates, 33% of our patients had their hypertensionprevalent. Interdialytic weight gain, interdialytic weight
controlled, and the predialysis BP and ambulatory BPvariation, and epoetin dose tended to be higher in pa-
rates were at goal levels in 53 and 22% of patients,tients who died from CV diseases during the follow-up.
respectively. Hence, the poor BP control observed in ourNo significant differences in heart rate, in the prevalence
cohort does not differ from the situation usually describedof controlled hypertension, and in the percentage of pa-
in hemodialysis patients, arguing for the usefulness oftients with adequate predialytic and ambulatory BP rates
our results in the general hemodialysis population.were observed between the two groups.
The influence of arterial hypertension on CV progno-
Hypertension control sis in ESRD patients is not as clear as in the general
population. Degoulet, Legrain, and Reach showed anNineteen out of 57 (33.3%) patients had their hyper-
association between both systolic and diastolic BPs andtension controlled (office BP , 140/90 mm Hg). Con-
CV mortality in 1453 prospectively studied dialysis pa-trolled hypertensives had lower 24-hour, daytime, and
tients [25]. Tomita, Kimura, and Inoue confirmed thenighttime BP than uncontrolled hypertensives, while a
prognostic role of systolic BP [26]. In a retrospectivenonsignificant difference was observed in dipper status
study by Duranti, Imperiali, and Sasdelli, no significant(Table 2). In 34 out of 57 (59.6%) patients and in 13 out
difference in survival was found between 168 normoten-of 57 (22.9%) patients, predialytic BP and ambulatory
sive and 202 hypertensive patients [27]. Moreover, theBP were, respectively, at goal (predialytic BP # 150/90
deleterious influence of low diastolic BP has been sug-mm Hg; 24-h ambulatory BP # 125/80 mm Hg).
gested in many reports. A “U” curve between systolic BP
Predictors of CV mortality and CV prognosis has been found by Zager et al in a
large longitudinal study [8]. Kimura et al showed that inTable 3 represents unadjusted relative risks of CV
patients with ischemic heart disease, survival curves weredeath in the study population. As assessed by Cox analy-
better in patients with high office systolic BP measure-sis, the significant predictors of CV mortality were: low
ments than in normotensives [10]. A correlation betweendiastolic BP, elevated 24-hour daytime, and nighttime
low diastolic BP, hypoalbuminemia, and risk of deathambulatory systolic BP, elevated 24-hour ambulatory PP
has been established by Iseki et al in a cohort of 1243and nondipper status. Figure 1 shows the probability of
CV survival in dippers and nondippers. A comparison chronic hemodialysis patients [28]. In agreement with
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Table 1. Baseline characteristics of our study group according to prognosis
Cardiovascular deaths Others
N 5 10 N 5 47 P value
Age years 66.8066.94 54.77616.88 0.03
Sex males/females 9/1 21/26 0.01
Diabetes mellitus % 3(30) 5(10.64) 0.14
Dialysis duration before inclusion years 6.0065.55 5.1965.21 0.66
BMI kg/m2 21.3163.06 23.3264.37 0.17
Life-long smoking level pack/years 22.90615.37 7.67615 0.005
Previous cardiovascular events % 9(90.00) 13(27.60) 0.0004
Interdialytic weight gain kg 2.4660.73 1.9660.79 0.07
Interdialytic weight variation % 4.1561.28 3.2561.39 0.06
Antihypertensive drugs
Calcium channel blockers % 8(80) 31(65.96) 0.62
ACE inhibitors % 8(80) 23(48.94) 0.14
Beta blockers % 2(20) 5(10.64) 0.77
Central acting drugs % 2(20) 4(8.51) 0.61
Number of antihypertensive drugs 2.0060.81 1.3660.48 0.001
Monotherapy % 2(20) 30(63.83) 0.007
Hb g/dL 9.9061.29 9.8861.14 0.97
EPO therapy % 8(80) 37(82.22) 0.73
EPO dose IU/kg/week 121.77679.99 78.93661.88 0.06
Albuminemia g/L 37.3063.71 39.8363.52 0.04
Calcemia mmol/L 2.4160.39 2.2860.15 0.08
Phosphoremia mmol/L 1.9860.93 1.8260.67 0.51
Parathormone pg/mL 61.72661.2 131.956145.37 0.14
Alkaline phosphatase IU/L 180.1655.89 144.44650.60 0.05
Total cholesterol mmol/L 5.7161.50 5.2261.16 0.31
Triglycerides mmol/L 2.2260.82 1.7460.72 0.10
Kt/V 1.2960.14 1.3060.20 0.91
Office blood pressure
Systolic blood pressure mm Hg 143.6616.86 145.04621.41 0.84
Diastolic blood pressure mm Hg 76.4610.34 85.83611.19 0.02
Controlled hypertensives % 4(40) 15(31.91) 0.72
Predialytic blood pressure
Systolic blood pressure mm Hg 146.14623.67 143.6624.92 0.76
Diastolic blood pressure mm Hg 79.97613.17 68.5617.92 0.02
Patients with adequate predialytic blood
pressure % 6(60) 28(59.57) 0.98
Ambulatory blood pressure
24-hour systolic blood pressure mm Hg 152.22619.92 137.84615.72 0.02
24-hour diastolic blood pressure mm Hg 80.07612.93 82.18611.28 0.64
24-hour pulse pressure mm Hg 72.15615.14 55.71613.02 0.0009
24-hour heart rate bpm 78.8616.54 82.9611.96 0.36
Daytime systolic blood pressure mm Hg 153.7621.95 138.76616.16 0.02
Daytime diastolic blood pressure mm Hg 81.8615.25 83.21611.71 0.74
Nighttime systolic blood pressure mm Hg 158.7621.48 134.23618.85 0.0006
Nighttime diastolic blood pressure mm Hg 81.9612.78 77.89612.54 0.36
Dipper % 2(20) 28(59.57) 0.03
Patients with adequate ABP level % 1(10) 13(27.66) 0.23
Data are expressed as unadjusted mean 6 standard deviation.
Abbreviations are: BMI, body mass index; ACE, angiotensin-converting enzyme; Hb, hemoglobulin; EPO, erythropoietin; Kt/V, dialysis dose; bpm, beats per
minute.
our data, an association of both CV mortality and low ment. On the other hand, it could be hypothesized that
office BP and predialytic BP measurements represent adiastolic BP already has been established by Blacher
et al [9]. However, no significant relationship between pressor test, and that treated hypertensive dialysis pa-
tients with a lower pressor response triggered by thediastolic ambulatory BP (nighttime, daytime, or 24-h
diastolic BP) and CV prognosis was observed in our doctor in the office or by the nurse before fistula puncture
are at greater CV risk. An underlying CV disease couldstudy group. This discrepancy also was not found in a
general Japanese population in whom the prognostic be responsible for this lower pressor response. Standard-
ized pressor tests need to be used to test this hypothesis.significance of ambulatory BP versus screening BP has
been studied [12]. However, ESRD patients differ from Arterial hypertension in ESRD patients is character-
ized by an increased PP [30], and the role of aortic stiff-a general population particularly by the vascular disease
[29] and the prevalence of circadian BP rhythm impair- ness in these alterations in pulsatile arterial dynamics
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Table 2. Ambulatory blood pressure in controlled and uncontrolled hypertensive subjects
Controlled HT Uncontrolled HT
N 5 19 N 5 38 P value
Office blood pressure
Systolic blood pressure mm Hg 122.79613.31 155.78613.44 0.0001
Diastolic blood pressure mm Hg 74.9566.44 88.79610.77 0.0001
Ambulatory blood pressure
24-hour systolic blood pressure mm Hg 129.89612.00 145.55617.21 0.0008
24-hour diastolic blood pressure mm Hg 77.8967.43 83.74612.79 0.07
24-hour pulse pressure mm Hg 52610.8 61.81615.33 0.36
24-hour heart rate bpm 81612.24 83.02613.23 0.58
Daytime systolic blood pressure mm Hg 131.63615.79 146.26617.24 0.003
Daytime diastolic blood pressure mm Hg 79.5869.56 84.66613.21 0.14
Nighttime systolic blood pressure mm Hg 128.89619.28 143.34620.87 0.01
Nighttime diastolic blood pressure mm Hg 73.9569.41 80.92613.39 0.05
Dippers % 11(57.89) 19(50) 0.57
Patients with adequate ABP level % 8(42.11) 6(15.79) 0.02
Abbreviations are: HT, hypertension; ABP, ambulatory blood pressure.
Table 4. Adjusted relative risk of cardiovascular death assessed byTable 3. Relative risk of cardiovascular death assessed by Cox
proportional hazards models multivariate Cox proportional hazards models (adjustments are
made for age, sex, and cardiovascular history)
Relative risk
(95% confidence limits) P value Relative risk
(95% confidence limits) P value
Office blood pressure
Systolic BP 0.95 (0.69–1.31) 0.75 Office blood pressure
Systolic blood pressure 0.99 (0.77–1.28) 0.94Diastolic blood pressure 0.43 (0.22–0.83) 0.01
Controlled vs. Diastolic blood pressure 0.49 (0.25–0.93) 0.03
Controlled versusnoncontrolled HT 0.59 (0.17–2.10) 0.42
Ambulatory blood pressure noncontrolled HT 0.70 (0.19–2.49) 0.58
Ambulatory blood pressure24-hour systolic blood
pressure 1.61 (1.10–2.34) 0.01 24-hour systolic blood
pressure 1.37 (0.95–1.96) 0.0924-hour diastolic blood
pressure 0.88 (0.50–1.54) 0.66 24-hour diastolic blood
pressure 0.93 (0.48–1.82) 0.8424-hour pulse pressure 1.85 (1.28–2.65) 0.0009
Daytime systolic blood 24-hour pulse pressure 2.05 (1.09–3.84) 0.03
Daytime systolic bloodpressure 1.62 (1.12–2.36) 0.01
Daytime diastolic blood pressure 1.38 (0.97–1.96) 0.08
Daytime diastolic bloodpressure 0.93 (0.55–1.58) 0.78
Nighttime systolic blood pressure 1.04 (0.57–1.91) 0.89
Nighttime systolic bloodpressure 1.59 (1.21–2.08) 0.0008
Nighttime diastolic blood pressure 1.41 (1.08–1.84) 0.01
Nighttime diastolic bloodpressure 1.27 (0.79–2.05) 0.32
Nondippers versus dippers 4.81 (1.02–22.66) 0.05 pressure 1.40 (0.84–2.34) 0.19
Nondippers versus dippers 4.61 (0.97–21.99) 0.06HT is hypertension.
For continuous variables, relative risks of cardiovascular death associated with HT is hypertension.
a 10 mm Hg increase in blood pressure and in pulse pressure are presented, For continuous variables, relative risks of cardiovascular death associated with
whereas for binary variables, relative risks between the two groups are given. a 10 mm Hg increase in blood pressure and in pulse pressure are presented,
whereas for binary variables, relative risks between the two groups are given.
has been pointed out [31]. We showed that 24-hour PP
both normotensives and hypertensives [33, 34]. Also,is a prognostic factor of CV mortality in our cohort.
Verdecchia et al demonstrated that ambulatory PP is aWith respect to mechanisms, elevated PP causes greater
potent risk marker in untreated essential hypertensivesstretch of arteries and favors arterial damage. In a longi-
[35]. In agreement with these data, we show that intudinal study, Lakka et al showed that elevated PP accel-
treated hypertensive hemodialysis patients, 24-hour PPerates the progression of preclinical atherosclerosis [32].
is a potent prognostic factor of CV mortality. ProspectiveMoreover, elevated PP may be linked to high systolic BP,
studies are needed to assess the influence of antihyper-which favors left ventricular hypertrophy and increases
tensive treatment on CV prognosis through its effect onmyocardial oxygen demand, whereas the decrease in dia-
PP in this high-risk group.stolic BP reduces the pressure on which coronary flow
The prognostic role of nondipper status on CV prog-is dependent and together predispose the heart to ische-
nosis [11, 12] and the deleterious influence of nighttimemia. Longitudinal studies have widely shown that high
PP values are a predictor of myocardial infarction in systolic BP on target organ have been established [13].
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nal BP emphasize the usefulness of ambulatory BP moni-
toring in nephrology. The prognostic role of nighttime
BP and of 24-hour PP on CV mortality suggests investi-
gating whether nocturnal BP and 24-hour PP are superior
to office BP as targets for antihypertensive therapy in
hypertensive hemodialysis patients in prospective ran-
domized trials.
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